Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy

P Dangsuwan, T Manchana - Gynecologic oncology, 2010 - Elsevier
OBJECTIVE: To compare the incidence of repeated red blood cell (RBC) transfusion in
anemic gynecologic cancer patients receiving platinum-based chemotherapy comparing …

Practical management of tyrosine kinase inhibitor-associated side effects in GIST

H Joensuu, JC Trent, P Reichardt - Cancer treatment reviews, 2011 - Elsevier
Patients diagnosed with advanced gastrointestinal stromal tumor (GIST) are currently treated
with oral tyrosine kinase inhibitors (TKIs). Imatinib mesylate is the standard first-line …

[图书][B] Transfusion medicine

J McCullough - 2021 - books.google.com
Explore this concise and clinically focused approach to the field of blood banking and
transfusion therapy The Fifth Edition of Transfusion Medicine delivers a succinct, thorough …

Hepatitis C virus treatment-related anemia is associated with higher sustained virologic response rate

MS Sulkowski, ML Shiffman, NH Afdhal, KR Reddy… - Gastroenterology, 2010 - Elsevier
BACKGROUND & AIMS: Hepatitis C virus (HCV) treatment is frequently complicated by
anemia from ribavirin (RBV)-related hemolysis and peginterferon-alfa (PEG-IFN)-related …

Experimental drugs for chemotherapy-and cancer-related anemia

C Madeddu, M Neri, E Sanna, S Oppi… - Journal of Experimental …, 2021 - Taylor & Francis
Anemia in cancer patients is a relevant condition complicating the course of the neoplastic
disease. Overall, we distinguish the anemia which arises under chemotherapy as pure …

Thrombotic complications of erythropoiesis-stimulating agents

G Lippi, M Franchini, EJ Favaloro - Seminars in thrombosis and …, 2010 - thieme-connect.com
The synthesis of erythropoiesis-stimulating agents (ESAs), especially recombinant human
erythropoietin, has provided a new therapeutic option for the treatment of patients with …

The role of erythropoietin and erythropoiesis-stimulating agents in tumor progression

BD Hedley, AL Allan, A Xenocostas - Clinical cancer research, 2011 - AACR
Over the past few decades, understanding of the physiologic function of erythropoietin (EPO)
has evolved significantly. EPO binds to erythropoietin receptors (EPOR), initiating signaling …

Intravenous iron supplementation for the treatment of chemotherapy-induced anaemia–systematic review and meta-analysis of randomised controlled trials

A Gafter-Gvili, B Rozen-Zvi, L Vidal, L Leibovici… - Acta …, 2013 - Taylor & Francis
Background: Current guidelines are inconclusive regarding intravenous (IV) iron for
treatment of chemotherapy-induced anaemia (CIA). Material and methods: Systematic …

Multiple‐dose, safety, pharmacokinetic, and pharmacodynamic study of sotatercept (ActRIIA‐IgG1), a novel erythropoietic agent, in healthy postmenopausal women

ML Sherman, NG Borgstein, L Mook… - The Journal of …, 2013 - Wiley Online Library
Ligands of the transforming growth factor‐beta superfamily and activin‐receptor signaling
play an important role in erythropoiesis. Sotatercept, an activin receptor type IIA (ActRIIA) …

Importance of hemoglobin concentration and its modification for the outcome of head and neck cancer patients treated with radiotherapy

CM Hoff - Acta Oncologica, 2012 - Taylor & Francis
Introduction. Hypoxia induced radioresistance has been acknowledged for decades. One of
the indirect evidences of the influence of hypoxia on radiation response comes from the …